← back to search

Cengiz Goekeri

Humboldt-Universität zu Berlin · DE
Area of research
Molecular Biology · Immunology
Research interest
Research interests include Immune Response and Inflammation, Pneumonia and Respiratory Infections, Single-cell and spatial transcriptomics, and Neonatal Respiratory Health Research.
h-index
7
citations
176
works
34
NIH funding
primary concept
email

Recent publications

Cell Surface RNA Expression Modulates Alveolar Epithelial Function
American Journal of Respiratory Cell and Molecular Biology 2025cited by 9position: middledoi
Trimodulin supports antibacterial defence and restricts inflammation in preclinical pneumonia models
European Respiratory Journal 2025cited by 1position: middledoi
Neutrophil-chemoattractant CXCL5 increases lung barrier permeability in acute lung injury
Mucosal Immunology 2025cited by 1position: middledoi
Enzymatic Modulation of the Pulmonary Glycocalyx Enhances Susceptibility to <i>Streptococcus pneumoniae</i>
American Journal of Respiratory Cell and Molecular Biology 2024cited by 8position: firstdoi
Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin–angiotensin–aldosterone system on COVID-19 disease
Virology Journal 2024cited by 8position: middledoi
Neural network-assisted humanisation of COVID-19 hamster transcriptomic data reveals matching severity states in human disease
EBioMedicine 2024cited by 4position: middledoi
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Nature Microbiology 2023cited by 79position: middledoi
MicroRNA-223 Dampens Pulmonary Inflammation during Pneumococcal Pneumonia
Cells 2023cited by 12position: firstdoi
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics
European Respiratory Review 2022cited by 14position: middledoi
Protocol to dissociate healthy and infected murine- and hamster-derived lung tissue for single-cell transcriptome analysis
STAR Protocols 2022cited by 7position: middledoi
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia
Critical Care 2018cited by 22position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Geraldine Nouailles · Humboldt-Universität zu Berlin8 papers (2018–2025)Peter Pennitz · Humboldt-Universität zu Berlin6 papers (2022–2025)Martin Witzenrath · German Centre for Cardiovascular Research6 papers (2018–2025)Achim D. Gruber · Technische Universität Berlin5 papers (2018–2025)Holger Kirsten · National University of Singapore4 papers (2022–2025)Markus Scholz · Life University3 papers (2022–2024)Emanuel Wyler · Institute of Virology of the Slovak Academy of Sciences3 papers (2022–2024)Elena López-Rodríguez · Humboldt-Universität zu Berlin3 papers (2024–2025) · 3 papers (2023–2024)Jakob Trimpert · Institute of Virology of the Slovak Academy of Sciences3 papers (2022–2024)Sandra Kunder · Berlin Institute of Health at Charité - Universitätsmedizin Berlin3 papers (2024–2025)Sandra-Maria Wienhold · Humboldt-Universität zu Berlin3 papers (2018–2025)Ulrike Behrendt · Humboldt-Universität zu Berlin3 papers (2018–2025)Kristina Dietert · Technische Universität Berlin3 papers (2018–2025)Norbert Suttorp · German Center for Lung Research3 papers (2018–2023)Wolfgang M. Kuebler · University of Toronto3 papers (2022–2025)Sarah Berger · Humboldt-Universität zu Berlin3 papers (2018–2025)Karen Hoffmann · Humboldt-Universität zu Berlin2 papers (2024–2025)K. Linke · Humboldt-Universität zu Berlin2 papers (2024–2025)Vladimir Gluhovic · Humboldt-Universität zu Berlin2 papers (2024–2025)